Spinal Cord Injury Treatment Market Trends
The Growing Impact of Spinal Cord Injuries on Older Adults
According to estimates from the National Spinal Cord Injury Association, approximately 282,000 individuals in the United States are affected by spinal cord injuries, with around 17,000 new cases diagnosed annually. As our world progresses, various factors like car accidents, falls, sports mishaps, and violent incidents contribute to the rising prevalence of spinal cord injuries, underscoring the need for spinal implants and devices.
With advancing age, individuals become more susceptible to spine-related issues such as degenerative disc disease and spinal cord injuries. As the global population ages, more people encounter these challenges.
Key Points on Spinal Injuries in Australia:
- Around 20,800 Australians have a spinal cord injury, typically caused by a traumatic event in their youth or middle age.
- Traumatic causes, including road accidents, falls, and sports injuries, account for 81% of spinal cord injuries in individuals under 65 years old.
- Non-traumatic causes, such as tumors and degenerative disorders, are the leading cause of spinal cord injuries in individuals over 65.
- Electrical Stimulation Systems: Researchers are developing systems that utilize electrical stimulation to restore hand function, postural control, and bowel and bladder control for individuals with spinal cord injuries, with funding from NINDS.
- Spinal Cord Stimulation: Another area of focus is stimulating the spinal cord below the injury level to support preserved cells and fibers in functioning properly, also supported by NINDS.
- Brain-Computer Interfaces (BCIs): Experimental BCIs are being pioneered to allow direct control of a computer cursor or robotic arm with brain signals, led by NINDS.
- KA-301: In August 2023, Kaneka Corporation began testing this treatment derived from stem cells obtained from human amnion (part of the placenta) on individuals with acute spinal cord injuries.
- NVG-291: In September 2023, NervGen Pharma Corporation administered the first dose of their experimental drug to a participant in a trial for spinal cord injuries, aiming to assess its efficacy.
- Spinal Implant Innovations: In October 2022, Rosies Base and SpineCraft joined forces to develop enhanced spinal implants utilizing nanoTi, a special type of titanium, for treating back injuries and related issues.